tiprankstipranks
Trending News
More News >
Spago Nanomedical AB (DE:7UX)
:7UX
Germany Market

Spago Nanomedical AB (7UX) Financial Statements

Compare
0 Followers

Spago Nanomedical AB Financial Overview

Spago Nanomedical AB's market cap is currently €11.00M. The company's EPS TTM is €-0.0019283250000000003; its P/E ratio is ―; Spago Nanomedical AB is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 1.91Mkr 1.20Mkr 1.05Mkr 660.00Kkr 342.00K
Gross Profitkr -12.36Mkr -23.28Mkr -15.60Mkr -16.78Mkr -416.00K
Operating Incomekr -33.71Mkr -42.51Mkr -39.47Mkr -39.19Mkr -18.96M
EBITDAkr -33.40Mkr -42.22Mkr -38.73Mkr -38.69Mkr -18.59M
Net Incomekr -32.51Mkr -42.22Mkr -39.31Mkr -39.08Mkr -18.90M
Balance Sheet
Cash & Short-Term Investmentskr 32.47Mkr 45.22Mkr 62.10Mkr 52.46Mkr 28.45M
Total Assetskr 39.58Mkr 52.98Mkr 205.95Mkr 191.62Mkr 162.82M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -32.47Mkr -45.22Mkr -62.10Mkr -52.46Mkr -28.45M
Total Liabilitieskr 2.28Bkr 11.67Mkr 8.80Mkr 6.81Mkr 3.15M
Stockholders' Equitykr -2.24Bkr 41.32Mkr 197.16Mkr 184.81Mkr 159.67M
Cash Flow
Free Cash Flowkr -34.67Mkr -45.41Mkr -42.02Mkr -40.20Mkr -25.15M
Operating Cash Flowkr -34.67Mkr -44.91Mkr -38.19Mkr -35.57Mkr -18.77M
Investing Cash Flowkr -230.00Kkr -506.00Kkr -3.83Mkr -4.63Mkr -6.38M
Financing Cash Flowkr 22.15Mkr 28.53Mkr 51.66Mkr 64.21Mkr 41.45M
Currency in SEK

Spago Nanomedical AB Earnings and Revenue History

Spago Nanomedical AB Debt to Assets

Spago Nanomedical AB Cash Flow

Spago Nanomedical AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis